Indivior Pharmaceuticals, Inc. Common Stock (INDV) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INDV. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 326 institutions reported holding INDV, with 120.9 million shares worth $5.0 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 18,709,432 | $768M | INCREASED |
| Vanguard | 14,125,841 | $580M | DECREASED |
| Oaktree Capital Management | 6,127,212 | $251M | DECREASED |
| State Street | 4,992,071 | $205M | INCREASED |
| Fuller & Thaler Asset Management | 4,615,816 | $189M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Jonathan Rubin (SVP, Chief Medical Officer) | OTHER | 1,617 | 2026-11-02 | |
| Jonathan Rubin (SVP, Chief Medical Officer) | OTHER | 1,886 | 2026-11-02 | |
| Jonathan Rubin (SVP, Chief Medical Officer) | OTHER | 1,886 | 2026-11-02 | |
| Jonathan Rubin (SVP, Chief Medical Officer) | OTHER | 1,540 | 2026-11-02 | |
| Jonathan Rubin (SVP, Chief Medical Officer) | OTHER | 1,155 | 2026-11-02 |
Full institutional holdings, insider history, and congressional trades for Indivior Pharmaceuticals, Inc. Common Stock on SentiSense.